Nea Management Company, LLC Verona Pharma PLC Transaction History
Nea Management Company, LLC
- $1.21 Billion
- Q2 2025
A detailed history of Nea Management Company, LLC transactions in Verona Pharma PLC stock. As of the latest transaction made, Nea Management Company, LLC holds 2,263,138 shares of VRNA stock, worth $238 Million. This represents 17.75% of its overall portfolio holdings.
Number of Shares
2,263,138
Previous 2,688,565
15.82%
Holding current value
$238 Million
Previous $171 Million
25.4%
% of portfolio
17.75%
Previous 16.19%
Shares
7 transactions
Others Institutions Holding VRNA
# of Institutions
322Shares Held
76.7MCall Options Held
977KPut Options Held
3.12M-
Janus Henderson Group PLC London, X06.13MShares$645 Million0.3% of portfolio
-
Perceptive Advisors LLC New York, NY5.51MShares$579 Million22.87% of portfolio
-
Darwin Global Management, Ltd. St. Helier, Y94.13MShares$434 Million16.48% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA3.38MShares$356 Million16.88% of portfolio
-
Rtw Investments, LP New York, NY3.05MShares$321 Million4.43% of portfolio
About Verona Pharma plc
- Ticker VRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,954,200
- Market Cap $6.41B
- Description
- Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...